Home › NDC Lookup › RxCUI directory › RxCUI 2672917

Chlophedianol hydrochloride 0.833 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution — RxCUI 2672917

RxNorm drug concept · Semantic clinical drug
RxCUI 2672917 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2672917
Official nameChlophedianol hydrochloride 0.833 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aschlophedianol hydrochloride 25 MG / pyrilamine maleate 50 MG per 30 ML Oral Solution; chlophedianol HCl 25 MG / pyrilamine maleate 50 MG in 30 mL Oral Solution; chlophedianol hydrochloride 12.5 MG / pyrilamine maleate 25 MG per 15 ML Oral Solution
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)212 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Chlophedianol hydrochloride 0.833 MG/ML / pyrila... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Chlophedianol hydrochloride 0.833 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution RxCUI 2672917

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Chlophedianol 21254
    • Pyrilamine 9009
    • Chlophedianol / pyrilamine 1429359
    • Chlophedianol hydrochloride 1014329
    • Pyrilamine maleate 82091
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Chlophedianol / pyrilamine Oral Solution 1429358
    • Chlophedianol hydrochloride / pyrilamine maleate Oral Solution 2649267
    • Chlophedianol / pyrilamine Oral Liquid Product 1429356
    • Chlophedianol / pyrilamine Oral Product 1429357
    • Chlophedianol hydrochloride / pyrilamine maleate Oral Liquid Product 2662534
    • Chlophedianol hydrochloride / pyrilamine maleate Oral Product 2660913
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Chlophedianol hydrochloride 0.833 MG/ML 2672916
    • Pyrilamine maleate 1.67 MG/ML 996587

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Chlophedianol hydrochloride 0.833 MG/ML SCDC · 2672916
  • Pyrilamine maleate 1.67 MG/ML SCDC · 996587
  • Chlophedianol / pyrilamine Oral Solution SCDF · 1429358
  • Chlophedianol hydrochloride / pyrilamine maleate Oral Solution SCDFP · 2649267
  • Chlophedianol / pyrilamine Oral Liquid Product SCDG · 1429356
  • Chlophedianol / pyrilamine Oral Product SCDG · 1429357
  • Chlophedianol hydrochloride / pyrilamine maleate Oral Liquid Product SCDGP · 2662534
  • Chlophedianol hydrochloride / pyrilamine maleate Oral Product SCDGP · 2660913

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2672917 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
58809-0189-08 237 mL in 1 BOTTLE (58809-189-08) VANACOF CP Allergy / Cough GM Pharmaceuticals, INC 2023-12-06
58809-0360-08 237 mL in 1 BOTTLE, PLASTIC (58809-360-08) Texaclear Fast Acting Allergy Relief GM Pharmaceuticals, INC 2014-10-21
Observed labelers: GM Pharmaceuticals, INC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.